Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 051651/0824 | |
| Pages: | 8 |
| | Recorded: | 01/29/2020 | | |
| Attorney Dkt #: | 11107-002US1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16349821
|
Filing Dt:
|
05/14/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/05/2019
| | | | |
|
Title:
|
A THERAPEUTIC OR PROPHYLACTIC AGENT FOR ISCHEMIC DISEASE, GLAUCOMA, OPTIC NERVE DISEASE, RETINAL DEGENERATIVE DISEASE, ANGIOGENIC RETINAL DISEASE, CANCER, NEURODEGENERATIVE OR AUTOIMMUNE DISEASE, AND A HYPOXIA INDUCING FACTOR INHIBITOR
|
|
|
Assignee
|
|
|
|
|
| 15-45, MITA 2-CHOME |
| MINATO-KU |
| TOKYO, JAPAN 1088345 |
|
|
Correspondence name and address
|
| |
MEUNIER CARLIN & CURFMAN LLC
|
| |
999 PEACHTREE STREET NE
|
| |
SUITE 1300
|
| |
ATLANTA, GA 30309
|
Search Results as of:
05/10/2024 09:26 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
